Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

Background With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the knowledge and attitudes of healthcare providers who are in charge of dispensing an...

Full description

Bibliographic Details
Main Authors: Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys
Format: Article
Language:English
Published: Taylor & Francis Group 2021-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:http://dx.doi.org/10.1186/s40545-021-00330-x